查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2083870

胜肽合成市場：依產品類型、技術、應用和最終用戶分類－2026-2032年全球市場預測

Peptide Synthesis Market by Product Type, Technology, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，胜肽合成市場將成長至 13.228 億美元，複合年成長率為 8.12%。

主要市場統計數據
基準年 2025 7.5389億美元
預計年份：2026年 8.1194億美元
預測年份 2032 13.0228億美元
複合年成長率 (%) 8.12%

胜肽合成正從一項專業研究服務轉變為策略性生物製造能力，應用於藥品、診斷試劑、疫苗、化妝品和先進材料等領域。經臨床驗證的胜肽療法因其高度靶向特異性、可預測的分解和可調控的藥物動力學特性，正在推動市場需求，尤其是在代謝性疾病、腫瘤、抗菌應用和罕見疾病領域。

該市場涵蓋固相胜肽合成、液相合成、混合方法、重組胜肽生產、純化技術以及符合GMP規範的合約開發與生產（CDMO）。產業領導者優先考慮高純度胜肽原料藥、長鏈和修飾序列的可擴展合成、環保溶劑、供應鏈的穩定性以及快速的分析核准，從而支持商業化和複雜的臨床研發管線。

胜肽合成領域的變革性變化

胜肽類藥物的快速商業化、GLP-1和多促效劑代謝療法的拓展，以及能夠以符合GMP規範的方式將複雜分子從毫克級放大到千噸的生產平台的需求，正在改變胜肽合成的模式。這種變化推動了對自動化合成儀、高通量純化、製程分析技術以及專業研發和生產能力的投資增加。

人工智慧對胜肽合成的累積影響

人工智慧（AI）正成為胜肽發現、可行性評估、合成規劃和品管等各階段的實用驅動力。 AI模型可以幫助篩檢肽庫、預測結合親和性、識別聚集和溶解度風險並提案序列修飾建議，從而在進行昂貴的實驗工作之前，優先篩選出穩定性高、免疫抗原性風險低的候選物質。

全球胜肽合成市場的主要區域趨勢

亞太地區正透過在中國和印度擴大製藥生產規模、在韓國和日本發展生物製藥和特種藥物生產能力​​以及在澳洲改善臨床研究基礎設施，不斷鞏固其作為胜肽合成成長引擎的地位。該地區受益於成本效益高的生產模式、強大的試劑和中間體供應商基礎，以及國內對糖尿病、肥胖、癌症和感染疾病治療藥物日益成長的需求。

胜肽合成成長叢集的關鍵群體特異性見解

東協市場在胜肽合成領域正日益佔據重要地位，這得益於新加坡的生物醫藥中心、馬來西亞的清真製藥生態系統、泰國的醫療旅遊中心以及越南和印尼不斷成長的醫療需求。儘管這些市場在區域分銷、臨床合作和特殊製劑策略方面極具吸引力，但高度符合GMP規範的胜肽原料藥生產仍集中在較成熟的製造群中。

深入了解影響胜肽合成需求的關鍵國家。

美國透過大力投資生物技術、進行先進的藥物研發活動、推動受FDA監管的臨床試驗計畫以及對商業化胜肽原料藥的需求，推動了胜肽合成的需求成長。加拿大憑藉其深厚的研究實力和臨床開發能力做出貢獻，而墨西哥在近岸外包、藥品包裝和區域准入方面的重要性日益凸顯。巴西則憑藉其大規模的醫療保健體系和不斷發展的製藥產業，為拉丁美洲地區的需求提供了支持。

為胜肽合成產業的領導者提供的實用建議

產業領導企業應優先考慮可擴展的GMP生產能力、早期製程開發以及針對長鏈、環狀、修飾和高活性胜肽的穩健分析控制策略。投資於自動化合成、高解析度純化、雜質庫和數位化批次文件的公司將更有利於降低開發風險並支持監管申報。

肽合成市場分析的調查方法

本執行摘要基於結構化的二級研究框架，該框架評估了同行評審的科學文獻、監管指南、公開資訊、臨床開發趨勢、專利趨勢、貿易數據以及醫療和製藥行業的權威資訊來源。評估重點關注檢驗的指標，例如藥物核准、生產投資、GMP要求、臨床研發管線趨勢以及區域產業政策。

結論：胜肽合成的策略展望

肽合成正處於高速發展階段，其驅動力包括檢驗治療效果的需求、對複雜生物活性分子的需求以及精準醫療的興起。最大的商業機會正湧現於藥物發現創新、GMP生產、卓越的分析能力和供應鏈韌性的交匯點。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 胜肽合成市場：依產品類型分類

  • 裝置
    • 層析法裝置
    • 冷凍乾燥機
    • 胜肽合成裝置
  • 試劑和耗材
    • 胺基酸
    • 耦合試劑
    • 染料和螢光標記試劑
    • 樹脂
  • 服務

第8章 胜肽合成市場：依技術分類

  • 混合技術
  • 液相胜肽合成
  • 固相胜肽合成

第9章：胜肽合成市場：依應用領域分類

  • 化妝品
  • 診斷
  • 研究與開發
  • 治療

第10章 胜肽合成市場：依最終用戶分類

  • 學術研究
  • 臨床實驗室
  • 受託研究機構
  • 製藥和生物技術公司

第11章 胜肽合成市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 胜肽合成市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 胜肽合成市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • 2B Scientific Limited
  • AAPPTec LLC
  • ABclonal, Inc.
  • Advanced ChemTech by Thorn BioScience LLC
  • Almac Group Limited
  • AmbioPharm Inc.
  • AnaSpec Inc.
  • Bachem AG
  • Biocon Limited
  • BioDuro LLC
  • Biosynth Ltd.
  • Biotage AB
  • CEM Corporation
  • CPC Scientific Inc.
  • Creative Diagnostics
  • CSBio Sciences Private Limited
  • Enamine Ltd.
  • GenScript Biotech Corporation
  • Gyros Protein Technologies AB by Mesa Laboratories, Inc.
  • JPT Peptide Technologies GmbH by TheraCode GmbH
  • Kaneka Corporation
  • LifeTein LLC
  • Merck KGaA
  • New England BioGroup, LLC
  • Novo Nordisk A/S
  • PolyPeptide Group AG
  • Thermo Fisher Scientific Inc.
  • USV Private Limited
Product Code: MRR-431388EE3B9B

The Peptide Synthesis Market is projected to grow by USD 1,302.28 million at a CAGR of 8.12% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 753.89 million
Estimated Year [2026] USD 811.94 million
Forecast Year [2032] USD 1,302.28 million
CAGR (%) 8.12%

Peptide synthesis is moving from a specialized research service into a strategic biomanufacturing capability for pharmaceuticals, diagnostics, vaccines, cosmetics, and advanced materials. Demand is being reinforced by clinically validated peptide therapeutics, especially in metabolic disorders, oncology, antimicrobial applications, and rare diseases, where peptides offer high target specificity, predictable degradation, and tunable pharmacokinetics.

The market is shaped by solid-phase peptide synthesis, liquid-phase synthesis, hybrid approaches, recombinant peptide production, purification technologies, and GMP-compliant contract development and manufacturing operations. Industry leaders are prioritizing high-purity peptide APIs, scalable synthesis of long and modified sequences, greener solvents, supply assurance, and faster analytical release to support commercial launches and complex clinical pipelines.

Transformative Shifts in the Peptide Synthesis Landscape

The peptide synthesis landscape is being transformed by the rapid commercialization of peptide drugs, the expansion of GLP-1 and multi-agonist metabolic therapies, and the need for manufacturing platforms that can scale complex molecules from milligrams to multi-kilogram GMP batches. This shift is intensifying investment in automated synthesizers, high-throughput purification, process analytical technology, and specialized development and manufacturing capacity.

At the same time, regulatory expectations for impurity profiling, nitrosamine risk management, extractables and leachables, and data integrity are raising the performance bar. Companies are responding with platformized SPPS workflows, orthogonal analytical methods such as LC-MS and HPLC, improved resin and coupling chemistries, and solvent-reduction initiatives to improve cost, quality, and environmental performance.

Cumulative Impact of Artificial Intelligence on Peptide Synthesis

Artificial intelligence is becoming a practical accelerator across peptide discovery, developability assessment, synthesis planning, and quality control. AI models help screen peptide libraries, predict binding affinity, flag aggregation and solubility risks, suggest sequence modifications, and prioritize candidates with stronger stability and lower immunogenicity risk before expensive laboratory work begins.

In manufacturing, machine learning supports route optimization, impurity prediction, chromatographic method development, batch monitoring, and deviation prevention. The strongest near-term value comes from combining AI with verified experimental datasets, electronic laboratory notebooks, and GMP-compliant validation; AI improves decision speed, but regulated peptide manufacturing still requires analytical confirmation, documented controls, and human scientific oversight.

Key Regional Insights Across Global Peptide Synthesis Markets

Asia-Pacific is strengthening its role as a peptide synthesis growth engine through expanding pharmaceutical manufacturing in China and India, biologics and specialty drug capabilities in South Korea and Japan, and clinical research infrastructure in Australia. The region benefits from cost-efficient production, a deep supplier base for reagents and intermediates, and increasing domestic demand for diabetes, obesity, oncology, and infectious-disease therapies.

North America remains a high-value center for peptide innovation due to the concentration of biotechnology companies, academic research, venture funding, FDA-regulated development programs, and specialized manufacturing capabilities in the United States and Canada. Latin America, led by Brazil and Mexico, is gaining relevance through branded generics, clinical trial participation, and public-health demand. Europe maintains strong leadership in quality systems, sustainable chemistry, and EMA-aligned GMP manufacturing, while the Middle East is investing in pharmaceutical localization through GCC industrial strategies. Africa is still emerging, with opportunities in diagnostics, antimicrobial research, local fill-finish, and regional supply-chain resilience.

Key Group Insights for Peptide Synthesis Growth Clusters

ASEAN markets are becoming more important to peptide synthesis through Singapore's biomedical hub, Malaysia's halal pharmaceutical ecosystem, Thailand's medical tourism base, and Vietnam and Indonesia's expanding healthcare demand. These markets are attractive for regional distribution, clinical partnerships, and specialty formulation strategies, although advanced GMP peptide API production remains concentrated in more mature manufacturing clusters.

The GCC is using healthcare diversification and life-science localization programs to reduce import dependence and attract pharmaceutical manufacturing. The European Union provides regulatory harmonization, high-quality manufacturing standards, and strong sustainability requirements that influence global peptide production practices. BRICS countries combine large patient populations with growing API capabilities, while G7 economies remain critical for innovation, intellectual property, premium manufacturing, and reimbursement access. NATO-aligned supply-chain policies are also increasing attention to secure sourcing of APIs, reagents, and critical laboratory materials.

Key Country Insights Shaping Peptide Synthesis Demand

The United States leads peptide synthesis demand through strong biotechnology funding, advanced drug discovery, FDA-regulated clinical pipelines, and commercial peptide API requirements. Canada contributes research depth and clinical development capabilities, while Mexico is increasingly relevant for nearshoring, pharmaceutical packaging, and regional access. Brazil anchors Latin American demand through its large healthcare system and expanding pharmaceutical sector.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support peptide innovation through academic research, specialty pharma, manufacturing networks, and regulated production expertise, while Russia maintains domestic pharmaceutical production priorities under supply-security pressures. China and India are pivotal for API scale, cost competitiveness, and supplier networks; Japan and South Korea emphasize high-quality manufacturing, innovation, and advanced therapeutics; and Australia contributes clinical research, translational science, and Asia-Pacific commercialization pathways.

Actionable Recommendations for Peptide Synthesis Industry Leaders

Industry leaders should prioritize scalable GMP capacity, early process development, and robust analytical control strategies for long, cyclic, modified, and highly potent peptides. Companies that invest in automated synthesis, high-resolution purification, impurity libraries, and digital batch documentation will be better positioned to reduce development risk and support regulatory submissions.

Executives should also diversify critical raw material sourcing, qualify dual suppliers, and build regional manufacturing redundancy to reduce disruption exposure. Strategic partnerships with AI-enabled discovery platforms, specialized manufacturers, resin suppliers, and formulation specialists can shorten timelines, while green chemistry programs focused on solvent reduction and waste management can improve both margins and ESG performance.

Research Methodology for Peptide Synthesis Market Analysis

This executive summary is based on a structured secondary research framework that evaluates peer-reviewed scientific literature, regulatory guidance, public disclosures, clinical development trends, patent activity, trade data, and recognized health and pharmaceutical industry sources. The assessment emphasizes verifiable indicators such as drug approvals, manufacturing investments, GMP requirements, clinical pipeline activity, and regional industrial policy.

Findings were synthesized through triangulation, competitive benchmarking, demand-side analysis, and supply-chain mapping. Insights were validated against known peptide manufacturing constraints, including sequence length, aggregation, impurity formation, purification yield, raw material availability, and regulatory expectations for identity, purity, potency, and stability.

Conclusion: Strategic Outlook for Peptide Synthesis

Peptide synthesis is entering a high-growth phase driven by therapeutic validation, demand for complex biologically active molecules, and the rise of precision medicine. The strongest opportunities are emerging where discovery innovation, GMP manufacturing, analytical excellence, and supply-chain resilience intersect.

Organizations that combine automated peptide synthesis, AI-assisted development, sustainable chemistry, and global regulatory discipline will be best positioned to capture value. As peptide drug pipelines expand, competitive advantage will increasingly depend on speed, quality, scalability, and the ability to manufacture complex sequences reliably at commercial scale.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Peptide Synthesis Market, by Product Type

  • 7.1. Equipment
    • 7.1.1. Chromatography Equipment
    • 7.1.2. Lyophilizers
    • 7.1.3. Peptide Synthesizers
  • 7.2. Reagents & Consumables
    • 7.2.1. Amino Acids
    • 7.2.2. Coupling Reagents
    • 7.2.3. Dyes & Fluroscent Labeling Reagents
    • 7.2.4. Resins
  • 7.3. Services

8. Peptide Synthesis Market, by Technology

  • 8.1. Hybrid Technology
  • 8.2. Liquid Phase Peptide Synthesis
  • 8.3. Solid Phase Peptide Synthesis

9. Peptide Synthesis Market, by Application

  • 9.1. Cosmetics
  • 9.2. Diagnosis
  • 9.3. Research & Development
  • 9.4. Therapeutics

10. Peptide Synthesis Market, by End-User

  • 10.1. Academic Research
  • 10.2. Clinical Laboratories
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotech Companies

11. Peptide Synthesis Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Peptide Synthesis Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Peptide Synthesis Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. 2B Scientific Limited
  • 15.2. AAPPTec LLC
  • 15.3. ABclonal, Inc.
  • 15.4. Advanced ChemTech by Thorn BioScience LLC
  • 15.5. Almac Group Limited
  • 15.6. AmbioPharm Inc.
  • 15.7. AnaSpec Inc.
  • 15.8. Bachem AG
  • 15.9. Biocon Limited
  • 15.10. BioDuro LLC
  • 15.11. Biosynth Ltd.
  • 15.12. Biotage AB
  • 15.13. CEM Corporation
  • 15.14. CPC Scientific Inc.
  • 15.15. Creative Diagnostics
  • 15.16. CSBio Sciences Private Limited
  • 15.17. Enamine Ltd.
  • 15.18. GenScript Biotech Corporation
  • 15.19. Gyros Protein Technologies AB by Mesa Laboratories, Inc.
  • 15.20. JPT Peptide Technologies GmbH by TheraCode GmbH
  • 15.21. Kaneka Corporation
  • 15.22. LifeTein LLC
  • 15.23. Merck KGaA
  • 15.24. New England BioGroup, LLC
  • 15.25. Novo Nordisk A/S
  • 15.26. PolyPeptide Group AG
  • 15.27. Thermo Fisher Scientific Inc.
  • 15.28. USV Private Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL PEPTIDE SYNTHESIS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PEPTIDE SYNTHESIS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PEPTIDE SYNTHESIS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PEPTIDE SYNTHESIS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CHROMATOGRAPHY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CHROMATOGRAPHY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CHROMATOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LYOPHILIZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LYOPHILIZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LYOPHILIZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PEPTIDE SYNTHESIZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PEPTIDE SYNTHESIZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PEPTIDE SYNTHESIZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AMINO ACIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AMINO ACIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AMINO ACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COUPLING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COUPLING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COUPLING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DYES & FLUROSCENT LABELING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DYES & FLUROSCENT LABELING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DYES & FLUROSCENT LABELING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RESINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RESINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RESINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HYBRID TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HYBRID TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HYBRID TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LIQUID PHASE PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LIQUID PHASE PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LIQUID PHASE PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SOLID PHASE PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SOLID PHASE PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SOLID PHASE PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COSMETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COSMETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 120. GCC PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 121. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 123. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 124. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 141. G7 PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 144. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 145. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 148. NATO PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 151. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 152. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 163. CANADA PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 166. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 167. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 170. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 173. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 174. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 177. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 180. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 181. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 191. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 194. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 195. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 198. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 201. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 202. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 205. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 208. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 209. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 212. ITALY PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 215. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 216. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 219. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 220. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 222. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 223. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 233. INDIA PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 236. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 237. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 240. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 243. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 244. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 247. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 250. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 251. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 254. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 257. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 258. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)